The GLP-1 Forecast: Key Predictions for 2024
Watch the Webinar Replay
AssuredPartners on April 25, discussed how the gene and cell therapy market continues to expand and develop targeted solutions for a wide range of diseases such as cancer, heart disease, and rare hematological conditions. During this session, we explored what actions plan sponsors should consider in order to build a long-term comprehensive management strategy for these therapies.
Watch the recorded webinar below.
Featured News & Insights
Watch the Webinar Replay Check out our latest webinar where we covered the critical aspects of managing healthcare data and its profound impact on funding strategies and plan design. We talked...
Watch the Webinar Replay Thank you for joining us for a panel discussion on the emerging trends and insights of the 2025 GLP-1 landscape. Our panelists joined us from AssuredPartners, Keenan, US-Rx...
Watch the Webinar Replay In celebration of American Heart Month, the American Heart Association wants to inspire you and your employees to take small steps to build healthier habits. This informative...